Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: Evidence that an initially deposited species is Aβ42(43)

Neuron

Volumn 13, Issue 1, 1994, Pages 45-53

  Iwatsubo, Takeshi ^a   Odaka, Asano ^c   Suzuki, Nobuhiro ^b   Mizusawa, Hidehiro ^d   Nukina, Nobuyuki ^b   Ihara, Yasuo ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c TAKEDA PHARMACEUTICAL COMPANY LIMITED   (Japan)

^d UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; MONOCLONAL ANTIBODY;

ALZHEIMER DISEASE; ARTICLE; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MORPHOMETRICS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SENILE PLAQUE;

ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANTIBODIES, MONOCLONAL; BRAIN; CEREBRAL CORTEX; FEMALE; HUMAN; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGE; MUTATION; PEPTIDE FRAGMENTS; SUPPORT, NON-U.S. GOV'T;

EID: 0028169925     PISSN: 08966273     EISSN: None     Source Type: Journal    
DOI: 10.1016/0896-6273(94)90458-8     Document Type: Article

References (41)

1. Release of excess amyloid β protein from a mutant amyloid β protein precursor
2. Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production
3. Is the “preamyloid” of diffuse plaques in Alzheimer's disease really nonfibrillar?
4. Cells with a familial Alzheimer's disease mutation produce authentic β-peptide
5. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease
6. Amyloid β-peptide is produced by cultured cells during normal metabolism
7. The lack of accumulation of senile plaques or amyloid burden in Alzheimer's disease suggests a dynamic balance between amyloid deposition and resolution
8. Seeding “one-dimensional crystallization” of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie?
9. The carboxy terminus of the β amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease
10. Protein chemical and immunocytochemical studies of meningovascular β-amyloid protein in Alzheimer's disease and normal aging
11. Diffuse amyloid plaques occur commonly in the cerebellum in Alzheimer's disease
12. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
13. Diagnosis of Alzheimer's disease
14. Formic acid pretreatment enhances immunostaining of cerebral and systemic amyloids
15. Familial Alzheimer's disease with the amyloid precursor protein 717 mutation and sporadic Alzheimer's disease have the same cytoskeletal pathology
16. Reversible in vitro growth of Alzheimer disease β-amyloid plaques by deposition of labeled amyloid peptide
17. Cerebral amyloidosis, ageing and Alzheimer's disease; a contribution from studies on Down's syndrome
18. The site of the earliest lesions of Alzheimer's disease (Letter)
19. Diffuse plaques do not accentuate synapse loss in Alzheimer's disease
20. Amyloid plaque core protein in Alzheimer disease and Down syndrome
21. Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer's disease
22. Mass spectrometry of purified amyloid (3 protein in Alzheimer's disease
23. Genetic and molecular advances in Alzheimer's disease
24. Clinical comparison of Alzheimer's disease in pedigrees with the codon 717 Val to lie mutation in the amyloid precursor protein gene
25. A pathogenetic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of β-amyloid
26. Mis-sense mutation Val to lie in exon 17 of amyloid precursor protein gene in Japanese familial Alzheimer's disease
27. Increased senile plaques without microglia in Alzheimer's disease
28. Differences between vascular and plaque core amyloid in Alzheimer's disease
29. Structural alterations in the peptide backbone of β-amyloid. core protein may account for its deposition and stability in Alzheimer's disease
30. β-amyloid-(1–42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease
31. The molecular pathology of Alzheimer's disease
32. Isolation and quantitation of soluble Alzheimer's j3-peptide from biological fluids
33. Production of the Alzheimer amyloid β protein by normal proteolytic processing
34. Different configurational states of β-amyloid and their distributions relative to plaques and tangles in Alzheimer disease
35. Modified Bielschowsky staining and immunohistochemical studies on striatal plaques in Alzheimer's disease
36. An increased percentage of long amyloid β protein is secreted by familial amyloid β protein precursor (βAPP717) mutants
37. tau protein kinase I is essential for amyloid β-protein-induced neurotoxicity
38. Characterization of β-amyloid peptide from human cerebrospinal fluid
39. Diffuse type of senile plaques in the brains of Alzheimer-type dementia
40. Diffuse type of senile plaques in the cerebellum of Alzheimer-type dementia demonstrated by j3 protein immunostain
41. Electron micrograph of diffuse plaques: initial stage of senile plaque formation in the Alzheimer brain